In a report released today, Jonathan Hughes from Raymond James maintained a Buy rating on MedEquities Realty Trust (MRT), with a price target of $10. The company’s shares closed yesterday at $7.42, close to its 52-week low of $7.32.
According to TipRanks.com, Hughes is a 3-star analyst with an average return of 3.5% and a 56.1% success rate. Hughes covers the Financial sector, focusing on stocks such as Senior Housing Properties Trust, Physicians Realty Trust, and Sabra Healthcare REIT.
MedEquities Realty Trust has an analyst consensus of Moderate Buy, with a price target consensus of $10.38, implying a 39.9% upside from current levels. In a report issued on November 13, B.Riley FBR also maintained a Buy rating on the stock with a $10.50 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $12 and a one-year low of $7.32. Currently, MedEquities Realty Trust has an average volume of 174.9K.
Based on the recent corporate insider activity of 45 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
MedEquities Realty Trust, Inc. operates as a real estate investment trust. It focuses on investment in healthcare properties and healthcare related real estate debt investments. It owns, develops, operates, leases, and disposes healthcare properties and portfolios. The company was founded in April 23, 2014 and is headquartered in Nashville, TN.
